Journal Summary - Discover more summaries and articles from M3 India

Oncology

Choose Topic

Etoposide as a single agent in the treatment of mycosis fungoides: A retrospective analysis

Dermatologic Therapy | Jan 14, 2018 General Oncology Pharmacology/Therapy Dermatologic Oncology

Maternal and fetal outcomes of pregnancies in women with atypical hemolytic uremic syndrome

Journal of the American Society of Nephrology | Jan 13, 2018 General Oncology Anemia/Polycythemia

The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer

International Journal of Cancer | Evidence based | Jan 13, 2018 General Oncology Pharmacology/Therapy Lung/Thoracic Oncology

Neoadjuvant dose dense MVAC vs GC in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy

The Journal of Urology | Jan 13, 2018 General Oncology Renal/Urologic Pharmacology/Therapy

Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer

Gynecologic Oncology | Jan 13, 2018 Pharmacology/Therapy General Oncology Gynecologic Oncology

Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): An exploratory, open-label, phase 2 study

The Lancet Oncology | Jan 12, 2018 Breast Pharmacology/Therapy General Oncology

Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): An international, randomised phase 3 trial

The Lancet Oncology | Jan 12, 2018 Renal/Urologic General Oncology

Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? Subgroup analysis of the METEOR trial

Journal of Clinical Oncology | Jan 12, 2018 General Oncology Pharmacology/Therapy Bone/Cartilage Renal/Urologic

Safety profile of biosimilar filgrastim (Zarzio/Zarxio): A combined analysis of phase III studies

The Oncologist | Jan 12, 2018 General Oncology Breast Pharmacology/Therapy

Bendamustine plus rituximab vs R-CHOP as first-line treatment for patients with follicular lymphoma grade 3A: Evidence from a multicenter, retrospective study

The Oncologist | Evidence based | Jan 12, 2018 Pharmacology/Therapy General Oncology Gynecologic Oncology

« Prev 1 … 1106 1107 1108 1109 1110 … 1255 Next »

Etoposide as a single agent in the treatment of mycosis fungoides: A retrospective analysis

Maternal and fetal outcomes of pregnancies in women with atypical hemolytic uremic syndrome

The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer

Neoadjuvant dose dense MVAC vs GC in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy

Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer

Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): An exploratory, open-label, phase 2 study

Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): An international, randomised phase 3 trial

Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? Subgroup analysis of the METEOR trial

Safety profile of biosimilar filgrastim (Zarzio/Zarxio): A combined analysis of phase III studies

Bendamustine plus rituximab vs R-CHOP as first-line treatment for patients with follicular lymphoma grade 3A: Evidence from a multicenter, retrospective study

Fibrate Therapy: Understanding the Risks

Polycystic Ovary Syndrome: Management Strategies

Patients with IBS Have a Higher Risk of These Debilitating Disorders

Anaesthetic Management in Obese Patients

Lasers: A Boon in Paediatric Dentistry

Etoposide as a single agent in the treatment of mycosis fungoides: A retrospective analysis

Maternal and fetal outcomes of pregnancies in women with atypical hemolytic uremic syndrome

The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer

Neoadjuvant dose dense MVAC vs GC in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy

Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer

Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): An exploratory, open-label, phase 2 study

Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): An international, randomised phase 3 trial

Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? Subgroup analysis of the METEOR trial

Safety profile of biosimilar filgrastim (Zarzio/Zarxio): A combined analysis of phase III studies

Bendamustine plus rituximab vs R-CHOP as first-line treatment for patients with follicular lymphoma grade 3A: Evidence from a multicenter, retrospective study

Fibrate Therapy: Understanding the Risks

Polycystic Ovary Syndrome: Management Strategies

Patients with IBS Have a Higher Risk of These Debilitating Disorders

Anaesthetic Management in Obese Patients

Lasers: A Boon in Paediatric Dentistry

Select Specialty

Select Topic